Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study.

Acta oncologica (Stockholm, Sweden) - 1 Jan 2009

Farjadfar Akbar, Mojtahedi Zahra, Ghayumi Mohammad Ali, Erfani Nasrollah, Haghshenas Mohammad Reza, Ghaderi Abbas

Abstract excerpt

BACKGROUND: Interleukin-18 (IL-18) is a multifunctional cytokine that augments IFN-gamma production and affects tumor immune response. In the present case-control study, we tested whether IL-18 promoter polymorphism contributes to lung cancer susceptibility in Iranian patients. MATERIAL AND METHODS: The study groups were 73 patients with lung cancer, including 53 with squamous carcinoma (SC) and 20 with small...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Haplotypes

Share to Interleukin-18

Share to Lung Neoplasms

Share to Promoter Regions, Genetic

Share to Small Cell Lung Carcinoma

Source

Identifiers

PMID: 19642044
DOI: 10.1080/02841860902878145

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study.PMID 19642044Read ↗

The -607C/A polymorphisms in interleukin-18 gene promoter contributes to cancer risk: evidence from a meta-analysis of 22 case-control studies.Semantic proximity Read ↗

Significant Contribution of Interleukin-18 Genotypes to Lung Cancer Risk in Taiwanese.Semantic proximity Read ↗

Association between IL18-607C/A and -137G/C polymorphisms and susceptibility to non-small cell lung cancer in a Chinese population.Semantic proximity Read ↗

Association of interleukin-18 gene promoter -607 C>A and -137G>C polymorphisms with cancer risk: a meta-analysis of 26 studies.Semantic proximity Read ↗

Increased cancer risk associated with the -607C/A polymorphism in interleukin-18 gene promoter: an updated meta-analysis including 12,502 subjects.Semantic proximity Read ↗

Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma.Semantic proximity Read ↗

The -137G>C polymorphism in interleukin-18 promoter region and cancer risk: evidence from a meta-analysis of 21 studies.Semantic proximity Read ↗

Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population.Semantic proximity Read ↗

Association of Interleukin-8 Promoter Genotypes With Taiwan Lung Cancer Risk.Semantic proximity Read ↗

The influence of Interleukin-6, Interleukin-8, Interleukin-10, Interleukin-17, TNF-A, MIF, STAT3 on lung cancer risk in Moroccan population.Semantic proximity Read ↗

Potential Impacts of Interleukin-17A Promoter Polymorphisms on the EGFR Mutation Status and Progression of Non-Small Cell Lung Cancer in Taiwan.Semantic proximity Read ↗

TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.